Fetal liver-derived mesenchymal stromal cells augment engraftment of transplanted hepatocytes.

ABSTRACT:

Background aims

One important problem commonly encountered after hepatocyte transplantation is the low numbers of transplanted cells found in the graft. If hepatocyte transplantation is to be a viable therapeutic approach, significant liver parenchyma repopulation is required. Mesenchymal stromal cells (MSC) produce high levels of various growth factors, cytokines and metalloproteinases, and have immunomodulatory effects. We therefore hypothesized that co-transplantation of MSC with human fetal hepatocytes (hFH) could augment in vivo expansion after transplantation. We investigated the ability of human fetal liver MSC (hFLMSC) to augment expansion of phenotypically and functionally well-characterized hFH.

Methods

Two million hFH (passage 6) were either transplanted alone or

SUBMITTER: Joshi M 

PROVIDER: S-EPMC3411318 | biostudies-literature | 2012 Jul

REPOSITORIES: biostudies-literature